↓ Skip to main content

The NMDA antagonist ketamine and the 5-HT agonist psilocybin produce dissociable effects on structural encoding of emotional face expressions

Overview of attention for article published in Psychopharmacology, July 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (94th percentile)
  • High Attention Score compared to outputs of the same age and source (93rd percentile)

Mentioned by

news
2 news outlets
patent
1 patent
facebook
1 Facebook page
pinterest
1 Pinner

Citations

dimensions_citation
70 Dimensions

Readers on

mendeley
192 Mendeley
Title
The NMDA antagonist ketamine and the 5-HT agonist psilocybin produce dissociable effects on structural encoding of emotional face expressions
Published in
Psychopharmacology, July 2012
DOI 10.1007/s00213-012-2811-0
Pubmed ID
Authors

André Schmidt, Michael Kometer, Rosilla Bachmann, Erich Seifritz, Franz Vollenweider

Abstract

Both glutamate and serotonin (5-HT) play a key role in the pathophysiology of emotional biases. Recent studies indicate that the glutamate N-methyl-D-aspartate (NMDA) receptor antagonist ketamine and the 5-HT receptor agonist psilocybin are implicated in emotion processing. However, as yet, no study has systematically compared their contribution to emotional biases.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 192 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 3 2%
United States 2 1%
Portugal 1 <1%
Czechia 1 <1%
Unknown 185 96%

Demographic breakdown

Readers by professional status Count As %
Student > Master 37 19%
Student > Bachelor 26 14%
Student > Ph. D. Student 23 12%
Researcher 20 10%
Other 13 7%
Other 28 15%
Unknown 45 23%
Readers by discipline Count As %
Psychology 48 25%
Neuroscience 36 19%
Medicine and Dentistry 23 12%
Agricultural and Biological Sciences 16 8%
Pharmacology, Toxicology and Pharmaceutical Science 3 2%
Other 14 7%
Unknown 52 27%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 21. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 August 2022.
All research outputs
#1,552,005
of 23,164,913 outputs
Outputs from Psychopharmacology
#366
of 5,378 outputs
Outputs of similar age
#9,618
of 165,496 outputs
Outputs of similar age from Psychopharmacology
#3
of 46 outputs
Altmetric has tracked 23,164,913 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,378 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.7. This one has done particularly well, scoring higher than 93% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 165,496 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 46 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 93% of its contemporaries.